Bionpharma endeavors to bring quality generics to the market across therapeutic areas. For doing so we constantly evaluate products that can add value to all stake holders and the health‐Care system. This enables us to work on the development of these products and put them through the FDA approval process. Bionpharma is engaged In product development in different geographies across the World.

At Bionpharma, our endeavor is to make the consumers aware of some basic facts about us and our medicines. This will enable us to perform the responsibility as a manufacturer and distributor of the pharmaceuticals in a more effective manner. We believe that in partnership with the consumers we will be able to serve them better. Here are some basic facts and helpful links that will help our consumers.

What is a Generic Drug?
A generic drug is identical--or bioequivalent--to a brand name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Although generic drugs are chemically identical to their branded counterparts, they are typically sold at substantial discounts from the branded price. According to the Congressional Budget Office, generic drugs save consumers an estimated $8 to $10 billion a year at retail pharmacies. Even more billions are saved when hospitals use generics. To learn more about generic drugs we encourage you to visit the following link:
All generic drugs go through a rigorous process of approval by the US FDA before it is brought on to the market for consumption

What is a “soft-gel capsule”:
Many of Bionpharma’s products are Soft-gel Capsules to be taken orally. So what is a soft-gel capsule? A softgel capsule is an oral dosage form for medicine similar to capsules. They consist of a gelatin based shell surrounding a liquid fill. Softgel shells are a combination of gelatin, water, opacifier and a plasticiser such as glycerin or sorbitol.